Majority
Headnote
To bring a case within the rule prohibiting the adoption of a word as a trade mark which is descriptive of the character and composition of the article to which it is applied, it must appear that the word gives some reasonably accurate and distinct knowledge upon those points.This action was tried by the court without a jury, and judgment was given in plaintiffs’ favor enjoining the defendants from the use of the words “ Bromo-Caffeine ” upon bottles containing a substance similar to that sold by the plaintiffs under that name. The injunction was granted on the ground that the defendants by such use of the above words infringed upon and violated the legal rights which the plaintiffs had acquired in the exclusive use of those words for the purposes of a trade mark.
The General Term of the Supreme Court reversed the judgment, and' granted a new trial, holding that the plaintiffs had established no legal right to the exclusive use of the words. It does not appear in the order of reversal that the General Term reversed the judgment upon any question of fact, and it must, therefore, be presumed that it was not reversed upon any such question. (Code of Civil Pro. § 1338.) If there be any evidence to sustain the findings of fact by the court, those findings are conclusive upon us, and the only question remaining would be whether those facts sustained the conclusions of law based upon them. The plaintiffs are manufacturers of chemical and also of medicinal preparations. In 1873 they began the manufacture of caffeine preparations, and they say that they practically created the demand in medicine for them in this country. They testified that they
The defendants urge that this case comes within the principles laid down in Caswell v. Davis ( 58 N. Y. 223 ), while the plaintiffs claim that it is like those cases where the trade mark; while more or less suggestive of the ingredients, characteristics or composition of the article to which it was applied, yet did not define the facts to such an extent as to thereby forfeit protection for the exclusive use of the words as a trade mark for the particular article manufactured.
- Before proceeding with the question further it will be well to see exactly what facts have been found by the trial court. It has been found that the manufacture of chemicals and of medicinal preparations are separate and distinct industries. In 1881 the plaintiffs commenced and have ever since continued the manufacture of a secret preparation of caffeine, composed of certain ingredients specially set out in the findings. This is a medical preparation and made for and adapted to the relief of headaches and other nervous disorders. In order to-distinguish the preparation from all others, and to establish a
In the year 1890 the defendants made a preparation similar to that of the plaintiffs, and intended for the same purpose, to which they applied the name of “ Bromide-Caffeine,” and subsequently they changed it to the name of “ Bromo-Caffeine,” and this name the defendants are still using to designate their preparation. It was further found that in the year 1867 a German chemist made a compound and called the same “ Bromo-Caffeine,” and an account of the making of the compound, including the process of making it, was published in a chemical journal at Leipsic in 1868. The formula is also to be found as published in Watts’ Dictionary of Chemistry, edition of 1872, and the article is called therein “ Bromo-Caffeine.” This chemical compound contains one portion of bromine, which is a virulent poison, and it is mixed in certain proportions with carbon, hydrogen, nitrogen and oxygen, and the result is that the caffeine entirely disappears. The evidence shows that the chemical compound thus described has no caffeine, but has bromine in it, and it is not an article of commerce nor is it generally known, and it is useless and valueless and unemployed, and outside the knowledge of expert or practical chemists. It is a mere curiosity of a chemical and not of a medicinal nature. While in the chemical compound the caffeine has wholly disappeared, and one atom of bromine
There is a finding that bromide of potassium and bromide of sodium were both well known to physicians prior to 1881, as possessing certain medical properties as sedatives, and the preparation sold by the plaintiffs contained the former bromide, while that sold by the defendants contained the latter, and both were mingled with caffeine and an effervescent salt and sugar and some other ingredients. The therapeutic effect of both bromides is substantially identical.
I think the finding of the court upon these facts is well
The word “ Bromo ” cannot be claimed as descriptive of the ingredient bromine, because the word is also used with regard to substances which have no bromine in them, but only some one of the different bromides. Neither does the word describe any particular bromide. Neither does it give any clue to the substance other than a bromide with which the bromine may have been compounded. The word fails in fact to give information as to what the ingredient is, further than a possibility as above suggested. This failure is very important, for unless the word give some reasonably accurate, some tolerably distinct knowledge as to what the ingredient is, it is clear that it is not descriptive within the meaning of that term as used with reference to a trade mark. When spoken of with refer
The testimony of Dr. Hamilton is not contrary to this statement. He said he did not know the ingredients composing the preparation, but supposed it might contain some preparation of the Bromo, but he did not know what it contained. He would understand from the use of the word “ Bromo ” that some form of bromide and caffeine are combined; the phrase “ Bromo-Caffeine ” vaguely conveyed to his mind that there was some preparation of bromide and caffeine together. The phrase, he said, was a term and not a scientific one, and he could not tell by the word “ Bromo ” what particular substance the bromide had combined with. The evidence shows that the word “Bromo” does not necessarily indicate the presence of any bromide. The word is just as descriptive and just as applicable in case bromine itself were the substance combined in the compound and not a bromide at all. The. word could only be said to inform one of the fact that bromine or some kind of bromide had entered into and formed part of the compound, but upon the question whether it was
We think there is a distinction between the facts in ..this case and that of Caswell v. Davis (supra). In this case the term perhaps suggests that some one among the hundreds of substances that bromine may combine with has been used in such combination together with caffeine. There are, however, some seven different ingredients in the plaintiffs’ preparation, and there is no free bromine among them, and there is no evi•dence as to what the substance is which the bromine (if any) had combined with before being used in the preparation, and so it is plain that the words “ Bromo-Caffeine ” do not in fact describe the ingredients or even give any clear general idea as t© what they are.
The plaintiffs adopted the words as a trade mark after consultation with counsel and before the name was in use in the United States as applied to any substance, while in the Caswell case the combined words were not ajiplied to the medicine as a name to designate the ownership, origin or particular manufacture of the preparation, but solely to indicate to physicians and the community of druggists the names of the three principal ingredients of which it was composed, and these three principal ingredients were known in materia medico and had been prescribed by physicians many years prior to 1860. The words did in fact show forth the quality and composition of the article sold. The name adopted was “ Ferro-Phosphorated Elixir of Calisaya Bark,” and it was said that they did indicate to the medical profession, to the community of druggists and to the public, the principal ingredients of which the article was composed. It also substantially indicated that the Calisaya bark was treated or had been subjected to the action of the two substances, iron and phosphorous, both of them old and well-known names of .articles used in medicine. All through the opinion of Judge
We think this case comes within the doctrine of those cases; which have protected the words as a trade mark although they suggested more or less the composition, quality or characteristics of the article. Some of the cases are alluded to in the opinion of Bapallo, J., in Selchow v. Baker ( 93 N. Y. 59 ) and the distinction is drawn in Electro-Silicon Co. v. Hazard ( 29 Hun, 369 ).
BTor do we think the words were in common use when applied by plaintiffs.
They had been used to designate a certain chemical compound as hereinbefore quoted from the findings of the trial judge, but, as stated therein, that compound was not in use and had no known useful quality and was but a chemical curiosity, and the words had no known significance in the medical world at the time when they were appropriated by the plaintiffs.
We think that there is evidence sufficient in this case to support the findings of fact made by the trial court and that such findings justify the conclusions of law based upon them.
The defendants should be enjoined from the further use of a name which the plaintiffs had legally appropriated as a trade mark many years prior to the time when the defendants commenced its use. We can see no reason for an appropriation of this name by the defendants other than that arising from an effort to convert to their own use and benefit the labor and skill of another. As this name adopted by plaintiffs does not describe the ingredients entering into defendants’ preparation, an injunction restraining the latter from the use of the name adopted by the plaintiffs can inflict no injustice upon defendants. And they should not be permitted to acquire any advantage to themselves by the unlicensed use of the plaintiffs’ trade mark. It could only be used by the defendants for
The order of the General Term should be reversed and the judgment entered upon the decision of the trial judge should be affirmed, with costs in all courts to the plaintiffs.
All concur.
. Ordered accordingly.
Cases cited
- Caswell v. Davis 58 N. Y. 223 p. 468, p. 469, p. 471
- Reese v. Smyth 95 N. Y. 645 p. 468
- Selchow v. Baker 93 N. Y. 59 p. 468, p. 477
- Newman v. Alvord 49 Barb. 588 p. 468, p. 469
- Newman v. Alvord 51 N. Y. 189 p. 468, p. 469
- Hier v. Abrahams 82 N. Y. 519 p. 468
- Burnett v. Phalon 9 Bosw. 192 p. 468
- Godillot v. Hazard 49 How. Pr. 5 p. 469
- Canal Co. v. Clark 13 Wall. 311 p. 469
- Wolfe v. Goulard 18 How. Pr. 64 p. 469
- Rillet v. Carlier 61 Barb. 435 p. 469
- Koehler v. Sanders 122 N. Y. 65 p. 469
- Davis v. Leopold 87 N. Y. 620 p. 469
- McCulloch v. Dobson 133 N. Y. 114 p. 469
- Amoskeag Manufacturing Co. v. Spear 2 Sandf. 599 p. 469
- Fetridge v. Wells 4 Abb. Pr. 144 p. 469, p. 470
- Wolfe v. Burke 56 N. Y. 115 p. 470